Early automated insulin delivery for new type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests whether starting an automated insulin delivery (AID) system soon after a type 1 diabetes diagnosis helps improve blood sugar control and reduces future health problems. The AID system combines a pump and continuous glucose monitor to automatically adjust insulin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 7 and 15 years old.
- You were diagnosed with type 1 diabetes within the last month.
- You do not have Addison's disease, kidney failure, untreated celiac disease, or untreated thyroid disorder.
- You do not have poorly controlled asthma.
- You do not have skin problems (like psoriasis, rash, or infection) where the glucose sensor would go.
- You have not been in another research study (drug or device) in the last 2 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether an automated insulin delivery system (often called an artificial pancreas) can help adults who have just been diagnosed with type 1 diabetes manage their blood sugar levels. It aims to improve long-term control and make day-to-day management easier.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study tests an early use of an automated insulin delivery system for people recently diagnosed with type 1 diabetes. The goal is to see if starting this technology soon after diagnosis helps with blood sugar control and quality of life.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests a smart insulin pump system that adjusts automatically during exercise. It aims to make managing blood sugar easier and safer.
This study tests a semi-automated insulin pump system in very young children (ages 2–6) with type 1 diabetes. It aims to see if the device improves quality of life and blood sugar control.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.